3,917 reports of this reaction
2.9% of all EPINEPHRINE reports
#3 most reported adverse reaction
SINUSITIS is the #3 most commonly reported adverse reaction for EPINEPHRINE, manufactured by Viatris Specialty LLC. There are 3,917 FDA adverse event reports linking EPINEPHRINE to SINUSITIS. This represents approximately 2.9% of all 135,553 adverse event reports for this drug.
Patients taking EPINEPHRINE who experience sinusitis should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
SINUSITIS is a less commonly reported adverse event for EPINEPHRINE, but still significant enough to appear in the safety profile.
In addition to sinusitis, the following adverse reactions have been reported for EPINEPHRINE:
The following drugs have also been linked to sinusitis in FDA adverse event reports:
SINUSITIS has been reported as an adverse event in 3,917 FDA reports for EPINEPHRINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
SINUSITIS accounts for approximately 2.9% of all adverse event reports for EPINEPHRINE, making it one of the most commonly reported side effect.
If you experience sinusitis while taking EPINEPHRINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.